9999999997-12-005808.txt : 20120405 9999999997-12-005808.hdr.sgml : 20120405 20120405095558 ACCESSION NUMBER: 9999999997-12-005808 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20120405 DATE AS OF CHANGE: 20120405 20120402 20120405 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CARACO PHARMACEUTICAL LABORATORIES LTD CENTRAL INDEX KEY: 0000887708 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 382505723 STATE OF INCORPORATION: MI FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-31773 FILM NUMBER: 12744016 BUSINESS ADDRESS: STREET 1: 1150 ELIJAH MCCOY DR CITY: DETROIT STATE: MI ZIP: 48202 BUSINESS PHONE: 3138718400 MAIL ADDRESS: STREET 1: 1150 ELIJAH MCCOY DRIVE CITY: DETROIT STATE: MI ZIP: 48202 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C$P(#`@;V)J#3P\+TQI;F5A7!E+UA2968O5ULQ(#(@,5T^/G-T#0IE;F1S M=')E86T-96YD;V)J#7-T87)T>')E9@T*,`T*)25%3T8-"B`@("`@("`@#0HR M,B`P(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O22`X-"],(#8X+TQE;F=T M:"`V,2]3(#,X/CYS=')E86T-"FC>8F!@8&9@8.)G``*.1@94P`C$+`P<#7!E+T-A=&%L;V<^/@UE;F1O8FH-,3(@ M,"!O8FH-/#PO0V]N=&5N=',@,30@,"!2+T-R;W!";WA;,"`P(#8Q,B`W.3)= M+TUE9&EA0F]X6S`@,"`V,3(@-SDR72]087)E;G0@."`P(%(O4F5S;W5R8V5S M(#$V(#`@4B]2;W1A=&4@,"]4>7!E+U!A9V4^/@UE;F1O8FH-,3,@,"!O8FH- M/#PO1FEL=&5R+T9L871E1&5C;V1E+T9I5H!$@.$_AZHK=[NU=9K4UZ-]E@K(XW`^';-+4%F-Y+BD98^B& ME.GA>=NL,F,7;'XS8;G9V^5PB/1O<_BER\Z@,P7!LM'AF$V!?^*2Y4\[OT*!I2%_U M@2&$8MGC3TL%Y>VC<96=RL.KUW;;+63$@5;$O>TOPH(@`,\AQDO[\M1?2LK# MEW8<*XB%`*42MX,D=2R*IV'H>1@GCL^*HMBA_AY^LOWE7D9>B#<YQS7W=.;0?MD*+\U.ET?(6B"2K`JXKP8]Z9RU_4FU7WKE,2?5R0/6K_\U[AN\6W9PYSBO8]J_"/``,#YB/T-"F5N9'-T(7Y*>(X5E89Z9>>:963Y!#FG)@ MD&X'C$.`?WCA8DSQ$@=C.HX@?1H$\#CP:1"P!-)\X!;/@V_DZW*1SCP_H@FY M@I7G"QJ3U*.,3%*[.W.;X/V=_C'P1S2.!?B,,@'IE<$,1@Y3+S3F:C;]>K]( M%QZ^'2$`3)97@$Y".B)_33]/EM?N!J9WM[>+U6IQM[3PXU=DC1=J8-^MG@=D MLJ]5`7P(/,#LO/3?`:?QZ"B<0!L$YEWSV&>..80L.1$*<) M\8YT[3']/(..*B1IYJB!R32%NSFP)-3,Y6Y=I[^;+$67 M)7=9@N?S6#`4V'&^WIB&Y(VD/4$%J3W$%L3E;_E.:!B^%EX[UN"6&T&@.:PM MIFJUT&/2R@UD)63[O8$LT$VKJA(.Y4;6<']`7IPR#/([E3*B)#Q:^QQJ^?T@ MFU:5CQI8_FQEV6C$:@L9[&OY0VD:V(@R=J30J--W9*"J0P./=5:VVBRORJW: M:*N8"FSDP`7`^@!"U\2R;%560%O+K-5Y)GH'ME7MDN#8P.,S>8_Z+!R(*M%` M6T?$H+XK9:>G/@O&C_44H)X^98WU4TND MOT%&3%I8[Q%I8/T"9X*+S@5GWCQJ-4^'VFKQC9RR<"IZB=[<92T28PR48\4% MV(_%Z(QEYEC^?L@*M44/D#6NY*Z<>?7T)"W#,8U97_\@[I..+6B=Z_>QW%M5 M9J6Y,7XTNR'1W@0YUK>NH6/9()\(0W3E"RWXO)9R4]GVT;)<=!F$#G.2MT,0 M\)6NZ)2"$/R!K!^\!Q)UK1D(<22/'M\T*7GPAB:>*_5#=0TSK72)QY1'KTF? MS4=2[_5$T`9SD[2$'1)HY@^/<0J*-[+R>[(&-LN%CM9D+/S@5&VGRHFHD]@D%)"&OZ@UV?_$R-&UCNATC&+TV[F40IK?4 M.:&NV4)R5"B.I^?9B9NNLWDDWJ^!#L\29H:-OFW5$^[)6E4;:/8R MU]+>?'3G@H7[OYXV7C#=*'%Y`703!SS=W`1;#Z7A\2@2FJ.Z.CSNW*/;K,Z[ M-8N&;L5UJW@Q#Q"KZT[T((X"P)^+P8351V07@3WZC@ZTX)T3[N(<=Q.)S!U# M4VQK+T::5:/U/M2CZ*P!+/DXQ]D;VK%-C]]CU44+#+$:=7/0YX'J%WLF['E>JSON#G$^K8W#]W]Y>FA7TT)GU-NPA6701["]+;YMU" M7?CO85T@4X/>A7'0%T%*>]?H=Y/SH$YC>4M&EXM9.OA/@`$`O78!D@T*96YD MG)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A M('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835`@ M0V]R92`T+C(N,2UC,#0S(#4R+C,W,C&UL;G,Z&UL;G,Z M9&,](FAT='`Z+R]P=7)L+F]R9R]D8R]E;&5M96YT"UD969A=6QT(CY-:6-R;W-O M9G0@5V]R9"`M($-A&UL M;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O(CX*("`@("`@ M("`@/'AM<#I#&UP.D-R96%T;W)4;V]L/E!38W)I M<'0U+F1L;"!697)S:6]N(#4N,BXR/"]X;7`Z0W)E871O&UP.DUE=&%D871A1&%T93X* M("`@("`@/"]R9&8Z1&5S8W)I<'1I;VX^"B`@("`@(#QR9&8Z1&5S8W)I<'1I M;VX@&UP34TZ26YS=&%N8V5)1#YU=6ED.C(W-F,P,3`S+30Q-F,M-#&UP34TZ26YS=&%N8V5)1#X*("`@("`@/"]R9&8Z M1&5S8W)I<'1I;VX^"B`@(#POJ'5!:DZ@E^@7+:X0Y[B<(<[>U*3U M7U'R0UN72H$?DCJ9T#KOO&V.G/Z+K/XBO7`:(XG91>%+4.ARU5P*":Q=ZQ#. MYI3OB9_U;&WSG;60.>:)K7Q5.+$DF,,^2(@,_1#D%B*-FF,H<`@7EM=AI@H' M30X^)9'8[?97@`$`UK--%@T*96YD7!E+UA2 M968O5ULQ(#(@,5T^/G-T